Status:

COMPLETED

Medical Cannabis as an Opiate Alternative

Lead Sponsor:

University of Pennsylvania

Conditions:

Chronic Pain

Opioid Use

Eligibility:

All Genders

18+ years

Brief Summary

Opioid use for pain has increased drastically over last decade with disastrous results that lead to an epidemic of overdoses and deaths in the United States. Philadelphia has been described as "ground...

Eligibility Criteria

Inclusion

  • Patient who are on chronic opioids medication for pain and have failed to wean off in past. These patients also have diagnoses that makes them eligible for medical marijuana and are willing to try it as an alternative to opioids -

Exclusion

  • History of Schizophrenia Acute psychiatric disorder Licensed to carry firearm Federal job that excludes them from receiving medical marijuana.
  • \-

Key Trial Info

Start Date :

October 11 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 6 2025

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT07194928

Start Date

October 11 2024

End Date

June 6 2025

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19146

Medical Cannabis as an Opiate Alternative | DecenTrialz